 Voyager Therapeutics, Inc NASDAQ: VYGR CEO and President Andre Turenne will step down as the beleaguered company announced it would move focus to early, discovery-stage efforts. The companys CMO and RD chief, Omar Khwaja, also stepped down after two years at the biotech. 